News
Guardian: HIV and Aids: bad news for drug prices in middle-income countries
[The Guardian] - "Abbott's preferential pricing policy for ritonavir has been in place, unchanged, for a decade," Dirk van Eeden, director of HIV communication and policy at Abbott, told IRIN/PlusNews via email. "It includes all African and least developed countries
Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New ...
www.europapress.es
Asia, North America and Latin America, Susan Beverly, + , or Europe and Africa, Dirk van Eeden, + , both of Abbott. Lo más leído. › notici...
AbbVie urges U.S. court to avoid gay rights issue in HIV drug case |...
www.reuters.com
An Abbott Laboratories spinoff urged a federal appeals court to revisit a ruling in a case against GlaxoSmithKline Plc, but without disturbing landmark...
Abbott reicht EU- und US-Zulassungsantrag für neue, niedriger...
www.finanznachrichten.de
Pressekontakt: Ansprechpartner Presse: Jennifer Smoter, Tel.: + oder Dirk van Eeden, Tel.: + , beide von Abbott ...
sortiert nach Relevanz / Datum